NCT00119301View on ClinicalTrials.gov

Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2007

Conditions
Sarcoma
Interventions
DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

trimetrexate glucuronate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00119301 - Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma | Biotech Hunter | Biotech Hunter